Delivering mitochondrial health
In June, Abliva will attend this year's edition of Euromit - the international conference on mitochondrial disease. The meeting takes place in Bologna, Italy, and gathers researchers, clinicians, and patients for […]
In late June, Abliva will be attending this year's international Mitochondrial Medicine Symposium, organized by US patient organization United Mitochondrial Disease Foundation. The meeting will take place in Charlotte, North Carolina […]
Abliva will participate at the 12th annual edition of 'The Future of Swedish & Danish Life Science', on September 7, 2023, in Lund, Sweden. The company's Chief Medical Officer, Magnus […]
During World Mitochondrial Disease Week, Abliva's Chief Medical Officer, Magnus Hansson, will present the company at the Cure Mito Foundation's Empower & Inspire - 2nd Annual Leigh Syndrome Symposium (virtual). […]
In mid-March, Abliva will attend the 8th edition of Mitochondrial Medicine - Therapeutic Development in Hinxton, UK. This annual scientific meeting is focused on mitochondrial disorders and the search for […]
Join Abliva for a virtual KOL event featuring Amel Karaa, MD (Massachusetts General Hospital), who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial […]
In late June, Abliva will attend the US patient organization UMDF’s Mitochondrial Medicine Conference in Cleveland, Ohio. "Each year, UMDF’s Mitochondrial Medicine Conference brings together the best minds in mitochondrial […]
In September, Abliva will attend the Nordic Life Science Days (NLS days) in Malmö, Sweden. Ablia's CEO, Ellen Donnelly, will be presenting the company at 11:00 a.m. CET on September […]
In late October, Abliva will attend the 14th Mitochondrial Disease Conference, this year in Padua (IT), organized by the Italian patient organization Mitocon. Abliva's CMO, Magnus Hansson will attend the […]
